-
1 Comment
Micro-X Limited is currently in a long term downtrend where the price is trading 0.5% below its 200 day moving average.
From a valuation standpoint, the stock is 93.2% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 17.6.
Micro-X Limited's total revenue rose by 46.4% to $4M since the same quarter in the previous year.
Its net income has dropped by 15.3% to $-5M since the same quarter in the previous year.
Finally, its free cash flow grew by 13.6% to $-2M since the same quarter in the previous year.
Based on the above factors, Micro-X Limited gets an overall score of 3/5.
| Sector | Healthcare |
|---|---|
| Industry | Medical Devices |
| ISIN | AU000000MX15 |
| Exchange | AU |
| CurrencyCode | AUD |
| Market Cap | 38M |
|---|---|
| Beta | 0.49 |
| PE Ratio | None |
| Target Price | 0.17 |
| Dividend Yield | None |
Micro-X Limited designs, develops, manufactures, and commercializes healthcare and security markets products using micro-X proprietary cold cathode X-ray technology in Australia, the United States, Asia-Pacific, Europe, the Middle East, and Africa. The company offers carbon nanotube-based X-ray products, including core X-ray tube and high-voltage generator components. It also provides Rover Plus for full medical performance in a mobile system; Head CT, a standard ambulance or retrieval aircraft for stroke; ARGUS for transforming stand-off imaging; Checkpoints, a modular passenger self-screening checkpoint for airports; and Baggage scanner, a CT baggage scanner for passenger self-screening checkpoints. Micro-X Limited was incorporated in 2011 and is based in Tonsley, Australia.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for MX1.AU using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025
